Severe Alopecia Areata Clinical Trials in Shanghai, Shanghai Municipality
3 recruitingShanghai, Shanghai Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Severe Alopecia Areata
Pfizer140 enrolled41 locationsNCT07029828
Recruiting
Phase 1
Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
HealthySevere Alopecia AreataActive Non-segmental Vitiligo
Innovent Biologics (Suzhou) Co. Ltd.160 enrolled1 locationNCT07554222
Recruiting
Phase 3
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Severe Alopecia Areata
Pfizer225 enrolled80 locationsNCT07029711